DaVita HealthCare Partner (DVA)
183.86
+0.77 (0.42%)
NYSE · Last Trade: Sep 19th, 5:19 AM EDT
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · September 17, 2026
DaVita’s 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may hav...
Via StockStory · September 8, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · September 4, 2026
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Via StockStory · September 2, 2026
DaVita (NYSE:DVA) Q2 2026: EPS Beats, Revenue In Line, Shares Fall 7.5%chartmill.com
Via Chartmill · August 4, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via StockStory · September 1, 2026
It's also not in the tech or finance sectors.
Via The Motley Fool · August 27, 2026
Mortality gains drove treatment growth despite payor mix headwinds.
Via The Motley Fool · August 11, 2026
DaVita’s second quarter results surpassed Wall Street’s revenue and adjusted profit expectations, but the market response was notably negative. Management at...
Via StockStory · August 11, 2026
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · August 5, 2026
These S&P500 stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · August 5, 2026
Top S&P500 movers in Wednesday's sessionchartmill.com
Via Chartmill · August 5, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2026, with sales up 5.2% year on year to $3.55 billion. Its non-GAAP ...
Via StockStory · August 5, 2026
Which S&P500 stocks are gapping on Wednesday?chartmill.com
Via Chartmill · August 5, 2026
Wondering what's happening in today's S&P500 pre-market session?chartmill.com
Via Chartmill · August 5, 2026
DaVita (NYSE:DVA) reported second-quarter results that management said were broadly in line with expectations, supported by accelerating treatment-volume growth and lower mortality among patients. The kidney-care company reaffirmed its full-year 2026 guidance, while outlining plans to expand access
Via MarketBeat · August 5, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2026, with sales up 5.2% year on year to $3.55 billion. Its non-GAAP ...
Via StockStory · August 4, 2026
Discover the top S&P500 movers in Tuesday's after-hours session.chartmill.com
Via Chartmill · August 4, 2026
Which S&P500 stocks have an unusual volume on Tuesday?chartmill.com
Via Chartmill · August 4, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. DaVita beat analysts’ revenue expec...
Via StockStory · August 2, 2026
What a time it’s been for DaVita. In the past six months alone, the company’s stock price has increased by a massive 122%, reaching $235.17 per share. This w...
Via StockStory · July 28, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Via StockStory · July 21, 2026
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via StockStory · July 14, 2026
Don't underestimate Ted Weschler's role in the post-Buffett era.
Via The Motley Fool · July 9, 2026